209 related articles for article (PubMed ID: 26621342)
1. Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.
Gee P; Schep LJ; Jensen BP; Moore G; Barrington S
Clin Toxicol (Phila); 2016; 54(2):141-6. PubMed ID: 26621342
[TBL] [Abstract][Full Text] [Related]
2. Application of a Urine and Hair Validated LC-MS-MS Method to Determine the Effect of Hair Color on the Incorporation of 25B-NBOMe, 25C-NBOMe and 25I-NBOMe into Hair in the Rat.
Nisbet LA; Venson R; Wylie FM; Scott KS
J Anal Toxicol; 2017 Jul; 41(6):559-565. PubMed ID: 28830123
[TBL] [Abstract][Full Text] [Related]
3. Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.
Laskowski LK; Elbakoush F; Calvo J; Exantus-Bernard G; Fong J; Poklis JL; Poklis A; Nelson LS
J Med Toxicol; 2015 Jun; 11(2):237-41. PubMed ID: 25387562
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
Wood DM; Sedefov R; Cunningham A; Dargan PI
Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
[TBL] [Abstract][Full Text] [Related]
5. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.
Tang MH; Ching CK; Tsui MS; Chu FK; Mak TW
Clin Toxicol (Phila); 2014 Jun; 52(5):561-5. PubMed ID: 24779864
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
Poklis JL; Raso SA; Alford KN; Poklis A; Peace MR
J Anal Toxicol; 2015 Oct; 39(8):617-23. PubMed ID: 26378135
[TBL] [Abstract][Full Text] [Related]
7. Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana During 2014.
Shanks KG; Sozio T; Behonick GS
J Anal Toxicol; 2015 Oct; 39(8):602-6. PubMed ID: 26378133
[TBL] [Abstract][Full Text] [Related]
8. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
Gatch MB; Dolan SB; Forster MJ
Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
[TBL] [Abstract][Full Text] [Related]
9. Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MS
Caspar AT; Brandt SD; Stoever AE; Meyer MR; Maurer HH
J Pharm Biomed Anal; 2017 Feb; 134():158-169. PubMed ID: 27915193
[TBL] [Abstract][Full Text] [Related]
10. Death after 25C-NBOMe and 25H-NBOMe consumption.
Morini L; Bernini M; Vezzoli S; Restori M; Moretti M; Crenna S; Papa P; Locatelli C; Osculati AMM; Vignali C; Groppi A
Forensic Sci Int; 2017 Oct; 279():e1-e6. PubMed ID: 28893436
[TBL] [Abstract][Full Text] [Related]
11. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
[TBL] [Abstract][Full Text] [Related]
12. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.
Kamińska K; Świt P; Malek K
J Anal Toxicol; 2021 Jan; 44(9):947-956. PubMed ID: 32128596
[TBL] [Abstract][Full Text] [Related]
13. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Stellpflug SJ; Kealey SE; Hegarty CB; Janis GC
J Med Toxicol; 2014 Mar; 10(1):45-50. PubMed ID: 23872917
[TBL] [Abstract][Full Text] [Related]
14. Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature.
Suzuki J; Dekker MA; Valenti ES; Arbelo Cruz FA; Correa AM; Poklis JL; Poklis A
Psychosomatics; 2015; 56(2):129-39. PubMed ID: 25659919
[TBL] [Abstract][Full Text] [Related]
15. Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series.
Hill SL; Doris T; Gurung S; Katebe S; Lomas A; Dunn M; Blain P; Thomas SH
Clin Toxicol (Phila); 2013 Jul; 51(6):487-92. PubMed ID: 23731373
[TBL] [Abstract][Full Text] [Related]
16. NBOMes-Highly Potent and Toxic Alternatives of LSD.
Zawilska JB; Kacela M; Adamowicz P
Front Neurosci; 2020; 14():78. PubMed ID: 32174803
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC-MS/MS in case of severe intoxications.
Wiergowski M; Aszyk J; Kaliszan M; Wilczewska K; Anand JS; Kot-Wasik A; Jankowski Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1041-1042():1-10. PubMed ID: 27992785
[TBL] [Abstract][Full Text] [Related]
18. Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication.
Poklis JL; Nanco CR; Troendle MM; Wolf CE; Poklis A
Drug Test Anal; 2014; 6(7-8):764-9. PubMed ID: 24000244
[TBL] [Abstract][Full Text] [Related]
19. A cluster of 25B-NBOH poisonings following exposure to powder sold as lysergic acid diethylamide (LSD).
Ivory ST; Rotella JA; Schumann J; Greene SL
Clin Toxicol (Phila); 2022 Aug; 60(8):966-969. PubMed ID: 35343858
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of 25B-, 25C-, 25D-, 25H-, 25I- and 25T2-NBOMe via LC-MS-MS: method validation and analyte stability.
Johnson RD; Botch-Jones SR; Flowers T; Lewis CA
J Anal Toxicol; 2014 Oct; 38(8):479-84. PubMed ID: 25217535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]